Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Science (New York, N.Y.) | Nov 28, 1997

http://www.ncbi.nlm.nih.gov/pubmed/9374462

A lymphocyte subpopulation, the Valpha14 natural killer T (NKT) cells, expresses both NK1.1 and a single invariant T cell receptor encoded by the Valpha14 and Jalpha281 gene segments. Mice with a deletion of the Jalpha281 gene segment were found to exclusively lack this subpopulation. The Valpha14 NKT cell-deficient mice could no longer mediate the interleukin-12 (IL-12)-induced rejection of tumors. Although the antitumor effect of IL-12 was thought to be mediated through natural killer cells and T cells, Valpha14 NKT cells were found to be an essential target of IL-12, and they mediated their cytotoxicity by an NK-like effector mechanism after activation with IL-12.

Pubmed ID: 9374462 RIS Download

Mesh terms: Animals | Anti-Bacterial Agents | Cytotoxicity, Immunologic | Gene Deletion | Gene Targeting | Genes, RAG-1 | Genes, T-Cell Receptor alpha | Interferon-gamma | Interleukin-12 | Killer Cells, Natural | Macrolides | Melanoma, Experimental | Mice | Mice, Inbred C57BL | Mice, Transgenic | Neoplasms, Experimental | Poly I-C | Proton-Translocating ATPases | Receptors, Antigen, T-Cell, alpha-beta | T-Lymphocyte Subsets

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.